Loading
institutionsInstitution
IRCCS Regina Elena National Cancer Institute
Rome's national cancer institute, which coordinates Italy's Alliance Against Cancer research network.
Also called: Istituto Nazionale Tumori Regina ElenaIFOIstituti Fisioterapici Ospitalieri
Overview
The Regina Elena National Cancer Institute, part of the Istituti Fisioterapici Ospitalieri with the San Gallicano dermatological institute, is Rome's IRCCS cancer hospital and coordinates Alleanza Contro il Cancro, the network of Italian oncology research institutes founded in 2002. Under scientific director Gennaro Ciliberto its research groups work on cancer vaccines and immunotherapy, p53 and non-coding RNA biology (Giovanni Blandino), tumour immunology (Paola Nisticò) and translational oncogenomics. Clinical programmes include melanoma and skin cancers, breast, thoracic and gynaecological oncology, robotic surgery, radiotherapy and a phase 1 unit, and the institute runs the Lazio regional oncology network with a large molecular tumour board.
Location
Rome, IT
Type
cancer center · Sapienza Università di Roma
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#180 · 30 points (0 Newsweek + 0 NCI + 30 from 15 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Instituto Nazionale Tumori Regina Elena, including child institutions. 37 works · 332 citations · 59% open access · 30% clinical trials · 3% reviews.
Oncology works per year
132022
102023
62024
42025
42026
Most works
- Federico Cappuzzo11 works
- Sara Pilotto7 works
- Stefania Gori6 works
- Diana Giannarelli6 works
- Lorenza Landi5 works
- Gabriele Minuti4 works
- Emilio Bria4 works
- Giulio Metro4 works
- Angelo Delmonte4 works
- Silvia Novello3 works
Most cited
- Alleanza Contro il Cancro coordination
- Immunotherapy and vaccine research
- Melanoma and skin cancers
- Robotic surgery
- Phase 1 unit
Giovanni Blandino
Scientific Director, IRCCS Regina Elena National Cancer Institute
Mutant p53 biologyTranslational oncologyCancer metabolism
Molecular oncologist known for mutant p53 research, appointed Scientific Director of Rome's Regina Elena National Cancer Institute in 2026.
Livio De Angelis
Representative of IRCCS Regina Elena National Cancer Institute to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Livio De Angelis represents IRCCS Regina Elena National Cancer Institute in the Organisation of European Cancer Institutes, which lists the centre among its members in Italy.
Similar pages
- PersonChristian Singer
Shares Journal of experimental & clinical cancer research, Ovarian cancer, HR-positive / HER2-negative breast cancer.
- PersonAntonio Rosato
Shares Journal of experimental & clinical cancer research, Melanoma.
- PersonAnna Fagotti
Shares Policlinico Universitario A. Gemelli, Ovarian cancer.
- InstitutionA.C. Camargo Cancer Center
Shares Robotic & minimally invasive surgery, TP53, Melanoma, HR-positive / HER2-negative breast cancer.
- TrialA Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Shares Personalised neoantigen (mRNA) vaccines, Melanoma, Immune checkpoint inhibitors.
- InstitutionLausanne University Hospital (CHUV) / Ludwig Institute Lausanne
Shares Personalised neoantigen (mRNA) vaccines, Ovarian cancer, Melanoma, Immune checkpoint inhibitors.
- TrialA Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (
Shares Personalised neoantigen (mRNA) vaccines, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionFondazione AIRC per la ricerca sul cancro
Shares Fondazione IRCCS Istituto Nazionale dei Tumori, Policlinico Universitario A. Gemelli.